CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home India’s CRDMO sector growth potential at $22 - $25 Billion by 2035, driving global pharma innovation: BCG-IPSO Report
News
26 Oct 2025

India’s CRDMO sector growth potential at $22 - $25 Billion by 2035, driving global pharma innovation: BCG-IPSO Report

India’s CRDMO sector growth potential at $22 - $25 Billion by 2035, driving global pharma innovation: BCG-IPSO Report

India’s CRDMO sector growth potential at $22 - $25 Billion by 2035, driving global pharma innovation: BCG-IPSO Report

Read PDF
Mentioned Companies
Aragen Life Sciences
View company profile
Related categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)